90 related articles for article (PubMed ID: 4292290)
1. Chemotherapy of glioblastoma multiforme: an appraisal.
Batzdorf U
Bull Los Angeles Neurol Soc; 1966 Oct; 31(4):164-76. PubMed ID: 4292290
[No Abstract] [Full Text] [Related]
2. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
Simpson L; Galanis E
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for glioblastoma: is costly better?
Linz U
Cancer; 2008 Nov; 113(10):2617-22. PubMed ID: 18833584
[No Abstract] [Full Text] [Related]
4. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
5. New developments in targeted molecular therapies for glioblastoma.
Wen PY
Expert Rev Anticancer Ther; 2009 Jan; 9(1):7-10. PubMed ID: 19105702
[No Abstract] [Full Text] [Related]
6. [Chemotherapy of glioblastomas].
Taillibert S
Soins; 2009 Mar; (733):38-9. PubMed ID: 19366001
[No Abstract] [Full Text] [Related]
7. Activity of bortezomib in glioblastoma.
Styczynski J; Olszewska-Slonina D; Kolodziej B; Napieraj M; Wysocki M
Anticancer Res; 2006; 26(6B):4499-503. PubMed ID: 17201170
[TBL] [Abstract][Full Text] [Related]
8. Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Addeo R; De Santi MS; Del Prete S; Caraglia M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):863-6. PubMed ID: 19639315
[No Abstract] [Full Text] [Related]
9. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
10. Drug cocktails for effective treatment of glioblastoma multiforme.
Debinski W
Expert Rev Neurother; 2008 Apr; 8(4):515-7. PubMed ID: 18416653
[No Abstract] [Full Text] [Related]
11. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.
Wheeler CJ; Das A; Liu G; Yu JS; Black KL
Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167
[TBL] [Abstract][Full Text] [Related]
12. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma.
Hamon F; Renoux B; Chadéneau C; Muller JM; Papot S
Eur J Med Chem; 2010 Apr; 45(4):1678-82. PubMed ID: 20116904
[TBL] [Abstract][Full Text] [Related]
13. Surgifoam and mitoxantrone in the glioblastoma multiforme postresection cavity: the first step of locoregional chemotherapy through an ad hoc-placed catheter: technical note.
Ferroli P; Broggi M; Franzini A; Maccagnano E; Lamperti M; Boiardi A; Broggi G
Neurosurgery; 2006 Aug; 59(2):E433-4; discussion E433-4. PubMed ID: 16883158
[TBL] [Abstract][Full Text] [Related]
14. Possible role for furazolidone in the treatment of glioblastoma multiforme.
Karamanakos PN
J BUON; 2013; 18(4):1097. PubMed ID: 24344045
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of brain tumors: biological basis of its limited efficacy].
Mousseau M
Bull Cancer; 1994 May; 81(5):414-24. PubMed ID: 7749219
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
17. Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly.
Shaw EG
J Clin Oncol; 2004 May; 22(9):1540-1. PubMed ID: 15051758
[No Abstract] [Full Text] [Related]
18. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
Reardon DA; Egorin MJ; Quinn JA; Rich JN; Gururangan S; Vredenburgh JJ; Desjardins A; Sathornsumetee S; Provenzale JM; Herndon JE; Dowell JM; Badruddoja MA; McLendon RE; Lagattuta TF; Kicielinski KP; Dresemann G; Sampson JH; Friedman AH; Salvado AJ; Friedman HS
J Clin Oncol; 2005 Dec; 23(36):9359-68. PubMed ID: 16361636
[TBL] [Abstract][Full Text] [Related]
20. Scintiphotographic evaluation of response of brain neoplasms to systemic chemotherapy.
Handel SF; Powell MR; Wilson CB; Enot KJ
J Nucl Med; 1971 Jun; 12(6):292-6. PubMed ID: 4325620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
